- Home
- CCIX vs CTNM Comparison
CCIX vs CTNM Comparison
Compare CCIX & CTNM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Company Overview
Basic Information| Metric | CCIX | CTNM |
|---|---|---|
| Founded | 2023 | 2009 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | |
| Sector | | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 390.8M | 416.1M |
| IPO Year | 2024 | 2024 |
Fundamental Metrics
Financial Performance| Metric | CCIX | CTNM |
|---|---|---|
| Price | $10.63 | $9.54 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $20.00 |
| AVG Volume (30 Days) | 102.9K | ★ 290.4K |
| Earning Date | 11-07-2013 | 10-30-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.25 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $42.57 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $10.30 | $3.35 |
| 52 Week High | $11.66 | $15.25 |
Technical Indicators
Market Signals| Indicator | CCIX | CTNM |
|---|---|---|
| Relative Strength Index (RSI) | 55.27 | 32.35 |
| Support Level | $10.61 | $11.66 |
| Resistance Level | $10.65 | $11.73 |
| Average True Range (ATR) | 0.03 | 0.78 |
| MACD | 0.01 | -0.32 |
| Stochastic Oscillator | 75.00 | 7.42 |
Price Performance
Historical Comparison CCIX
CTNM
About CCIX Churchill Capital Corp IX Ordinary Shares
Churchill Capital Corp IX is a blank check company.
About CTNM Contineum Therapeutics Inc.
Contineum Therapeutics Inc is a clinical stage biopharmaceutical company focused on discovering and developing novel, oral small molecule therapies for NI&I indications with high unmet need. Its internally-discovered drug candidates, PIPE-791 and PIPE-307, PIPE-791, is a novel, brain penetrant, small molecule inhibitor of the LPA1R in development for IPF and PIPE-307, is a novel, small molecule selective inhibitor of the muscarinic type 1 M1R, in development for depression and RRMS.